Drawing for GUIDEPX

USPTO serial 79285049

GUIDEPX

Reviewed by CopyMark Law Group

Reg. 6382768Status 700Renewal
Filing date
Status date
Registration date
Jun 15, 2021
Examiner
PODESTA, GIDETTE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GUIDEPX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica Bromall Sparkman

Jessica Bromall Sparkman Jeffer Mangels Butler & Mitchell LLP1900 Avenue of the Stars, 7th FloorLos Angeles, CA 90067UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Clinical diagnostic reagents for medical use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; pharmaceutical preparations for in vivo diagnostic or therapeutic use, namely, i-vivo diagnostic agent used for detection and monitoring of tumors; drug test kits containing medical diagnostic reagents and assays for testing of body fluidsACTIVE—
010Testing apparatus for medical purposes, namely, for testing blood, tissue biopsies, tumors, cells, cancer cells, DNA, RNA, biomarkers; apparatus for use in medical analysis, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; diagnostic apparatus for medical purposes, namely, detecting tumors; medical diagnostic apparatus for testing blood, tissue biopsies, tumors, cells, cancer cells, DNA, RNA, incorporating recorded software using a machine learning algorithm to examine genomic information and identify biomarkersACTIVE—
044Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 15, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 10, 2025LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jan 4, 2025LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Oct 24, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 29, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 29, 2021FIMPFINAL DISPOSITION PROCESSED—
Sep 15, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 15, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 30, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 30, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 28, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 10, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 10, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 10, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 23, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 23, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 23, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 22, 2021ALIEASSIGNED TO LIE—
Nov 19, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 17, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 17, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 17, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 19, 2020RFNTREFUSAL PROCESSED BY IB—
May 30, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 29, 2020RFRRREFUSAL PROCESSED BY MPU—
May 12, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 12, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
May 11, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2020DOCKASSIGNED TO EXAMINER—
May 8, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 7, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance